Skip to main content
Clinical Trials/NCT04248946
NCT04248946
Unknown
Not Applicable

Sham-controlled, Double-blind, Randomised Crossover Study of the Neural, Behavioural, and Clinical Effects of Transcranial Direct Current Stimulation in Patients With a Prolonged Disorder of Consciousness; Feasibility Study

University of Birmingham2 sites in 1 country15 target enrollmentJuly 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Consciousness Disorder
Sponsor
University of Birmingham
Enrollment
15
Locations
2
Primary Endpoint
Retention at 6 months
Last Updated
5 years ago

Overview

Brief Summary

This study evaluates the feasibility of an experimental protocol that combines advanced multi-modal imaging of the brain with clinical and behavioural scales to characterise the neural, behavioural, and clinical effects of transcranial direct current stimulation (tDCS) for rehabilitation in PDOC

Detailed Description

Patients with prolonged disorders of consciousness (PDOC) have very limited therapeutic options, and they often show little to no progress over time. Here, the investigators will assess whether transcranial direct current stimulation can improve patients' responsiveness. The investigators will use a protocol designed to target specific brain networks that have been shown to play a key role in explaining the lack of voluntary responses in PDOC. The study will focus on characterising the mechanisms of action of tDCS and the bases for potential individual differences in responsiveness to the stimulation across participants. This feasibility study is the first step towards developing personalised tDCS interventions to restore external responsiveness in PDOC patients. Its results will inform the design of a future trial fully powered for characterising neural, behavioural, and clinical effects of tDCS in PDOC as well as the mechanisms underlying individual differences in responsiveness.

Registry
clinicaltrials.gov
Start Date
July 2021
End Date
August 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or older
  • Receiving care at a recruitment site, with a consensus clinical diagnosis of PDOC from any aetiology (i.e. traumatic or non-traumatic injury).
  • Stable and with no need of mechanical support (i.e. respirator, etc.)

Exclusion Criteria

  • Scalp skin sores or any skin damage at the electrode sites
  • Metallic implants in the face or skull
  • Craniectomy or cranioplasty
  • No evidence of auditory startle in clinical observations, or absent brainstem auditory evoked potentials in recent clinical history (if data available)
  • MRI incompatible: metal plates incompatible with MRI scanners, pacemaker, inability to lay flat for prolonged periods of time, aneurysm clips, neurostimulators, brain/subdural electrodes, etc. (MRI stream ONLY)

Outcomes

Primary Outcomes

Retention at 6 months

Time Frame: 6 months after start of participation

percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only

Completion

Time Frame: through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream

percentage of tDCS, MRI, and electrophysiology assessments completed per polarity

Retention at end of active phase

Time Frame: through completion of active phase of study (tDCS intervention), on average 4 weeks for bedside stream and 8 weeks for MRI stream

percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure)

Retention at 3 months

Time Frame: 3 months after start of participation

percentage of participants on study at pre-specified time points counted from the start of participation in the study (i.e., first study procedure). This Outcome applies to the bedside stream only

Secondary Outcomes

  • Functional MRI in response to task instructions(day 1 and day 5 of tDCS each polarity)
  • EEG power in the beta band in response to task instructions(days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream)
  • EMG (electromyography) amplitude changes(days 1-4 and day 2 of each polarity in the MRI and bedside streams respectively)
  • Structural MRI(day 1 and day 5 of tDCS each polarity)
  • EEG power in the alpha band in response to task instructions(days 1 and 4 of each polarity in the MRI stream and day 1 of each polarity in the bedside stream)
  • Coma recovery scale -revised(regularly through active phase of study (baseline and outcome assessments), on average 4 weeks for bedside stream and 8 weeks for MRI stream)
  • Glasgow Outcome Scale-extended(at 3 and 6 months after start of participation)

Study Sites (2)

Loading locations...

Similar Trials